Retinopathy is considered one of the indicators of target organ damage. This review focuses on recent studies on hypertensive retinopathy and their implications for clinical care. Early recognition of ...

RhyGaze secured $86 million in a Series A financing round, which will be used to further the development of the company’s lead candidate gene therapy for optogenetic vision restoration ...

The FDA approved the Zeiss Mel 90 excimer laser for the treatment of myopia, hyperopia and mixed astigmatism, according to a press release.